Alternatively, injection of the v6 peptides that block the co-receptor functions of CD44v6 for MET and VEGFR-2 inhibited human pancreatic xenograft tumor growth and metastasis and decreased survival of KPC mice (Matzke-Ogi et al., 2016). This evidence concerns the gene MET and neoplasm.